These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10697998)

  • 1. [Clinical symptoms of and diagnostic possibilities for hypophyseal adenoma in horses].
    Feige K; Eser MW; Geissbühler U; Balestra E; Metzler K
    Schweiz Arch Tierheilkd; 2000 Feb; 142(2):49-54. PubMed ID: 10697998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of a combined dexamethasone suppression/thyrotropin-releasing hormone stimulation test in healthy horses and horses suspected to have a pars intermedia pituitary adenoma.
    Eiler H; Oliver JW; Andrews FM; Fecteau KA; Green EM; McCracken M
    J Am Vet Med Assoc; 1997 Jul; 211(1):79-81. PubMed ID: 9215417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical snapshot: Hirsutism in a pony.
    Stern A
    Compend Contin Educ Vet; 2013 Mar; 35(3):E6. PubMed ID: 23713162
    [No Abstract]   [Full Text] [Related]  

  • 4. Adrenocorticotropin-containing neoplastic cells in a pars intermedia adenoma in a horse.
    Horvath CJ; Ames TR; Metz AL; Larson VL
    J Am Vet Med Assoc; 1988 Feb; 192(3):367-71. PubMed ID: 2833479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenoma of the pars intermedia and hirsutism in a pony.
    Holscher MA; Linnabary RL; Netsky MG; Owen HD
    Vet Med Small Anim Clin; 1978 Sep; 73(9):1197-200. PubMed ID: 252364
    [No Abstract]   [Full Text] [Related]  

  • 6. Adrenocorticotropin concentration following administration of thyrotropin-releasing hormone in healthy horses and those with pituitary pars intermedia dysfunction and pituitary gland hyperplasia.
    Beech J; Boston R; Lindborg S; Russell GE
    J Am Vet Med Assoc; 2007 Aug; 231(3):417-26. PubMed ID: 17669045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Equine pituitary neoplasia: a clinical report of 21 cases (1990-1992).
    van der Kolk JH; Kalsbeek HC; van Garderen E; Wensing T; Breukink HJ
    Vet Rec; 1993 Dec; 133(24):594-7. PubMed ID: 8116170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunocytochemical localization of adrenocorticotropic hormone-immunoreactive cells of the pars intermedia in thoroughbreds.
    Okada T; Shimomuro T; Oikawa M; Nambo Y; Kiso Y; Morikawa Y; Liptrap RM; Yamashiro S; Little PB; Sasaki F
    Am J Vet Res; 1997 Aug; 58(8):920-4. PubMed ID: 9256982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory diagnosis of equine pituitary pars intermedia adenoma.
    van der Kolk JH; Wensing T; Kalsbeek HC; Breukink HJ
    Domest Anim Endocrinol; 1995 Jan; 12(1):35-9. PubMed ID: 7621678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid metabolism in horses with hyperadrenocorticism.
    van der Kolk JH; Wensing T; Kalsbeek HC; Breukink HJ
    J Am Vet Med Assoc; 1995 Apr; 206(7):1010-2. PubMed ID: 7768707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertrophic osteopathy in a pony with a pituitary adenoma.
    Sweeney CR; Stebbins KE; Schelling CG; Beech J; Schilling DA
    J Am Vet Med Assoc; 1989 Jul; 195(1):103-5. PubMed ID: 2759881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of pituitary gland anatomy and histopathologic findings in clinically normal horses and horses and ponies with pituitary pars intermedia adenoma.
    van der Kolk JH; Heinrichs M; van Amerongen JD; Stooker RC; in de Wal LJ; van den Ingh TS
    Am J Vet Res; 2004 Dec; 65(12):1701-7. PubMed ID: 15631037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the combined dexamethasone suppression/ thyrotropin-releasing hormone stimulation test for detection of pars intermedia pituitary adenomas in horses.
    Frank N; Andrews FM; Sommardahl CS; Eiler H; Rohrbach BW; Donnell RL
    J Vet Intern Med; 2006; 20(4):987-93. PubMed ID: 16955827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumors of the central nervous system.
    Paradis MR
    Vet Clin North Am Equine Pract; 1998 Dec; 14(3):543-61, vii. PubMed ID: 9891724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An epidemiological study of myopathies in Warmblood horses.
    Hunt LM; Valberg SJ; Steffenhagen K; McCue ME
    Equine Vet J; 2008 Mar; 40(2):171-7. PubMed ID: 18089471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenomas of the pars intermedia associated with hyperglycemia and glycosuria in two horses.
    Loeb WF; Capen CC; Johnson LE
    Cornell Vet; 1966 Oct; 56(4):623-39. PubMed ID: 6008349
    [No Abstract]   [Full Text] [Related]  

  • 17. Correlation of pituitary histomorphometry with adrenocorticotrophic hormone response to domperidone administration in the diagnosis of equine pituitary pars intermedia dysfunction.
    Miller MA; Pardo ID; Jackson LP; Moore GE; Sojka JE
    Vet Pathol; 2008 Jan; 45(1):26-38. PubMed ID: 18192571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agreement in histologic assessments of the pituitary pars intermedia in aged horses.
    McFarlane D; Miller LM; Craig LE; Dybdal NO; Habecker PL; Miller MA; Patterson JS; Cribb AE
    Am J Vet Res; 2005 Dec; 66(12):2055-9. PubMed ID: 16379646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTP Toxicology and Carcinogenesis Studies of Diethylphthalate (CAS No. 84-66-2) in F344/N Rats and B6C3F1 Mice (Dermal Studies) with Dermal Initiation/ Promotion Study of Diethylphthalate and Dimethylphthalate (CAS No. 131-11-3) in Male Swiss (CD-1(R)) Mice.
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1995 May; 429():1-286. PubMed ID: 12616302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computed tomographic evaluation of head diseases in the horse: 15 cases.
    Tietje S; Becker M; Böckenhoff G
    Equine Vet J; 1996 Mar; 28(2):98-105. PubMed ID: 8706655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.